KPW
GRTS

Kore Private Wealth’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Kore Private Wealth’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,000
Closed -$6K – 1291
2020
Q1 		$6K Hold
1,000
– – ﹤0.01% 789
2019
Q4 		$9K Buy
+1,000
New +$8.34K ﹤0.01% 772

Other funds holding GRTS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Kore Private Wealth's GRTS Position: Q2 2020 in Review

Kore Private Wealth sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2020, closing a stake of 1,000 shares — an estimated $6K sold.

Kore Private Wealth first reported a position in GRTS in Q4 2019 and held it in 2 quarters. The position peaked at $9K in Q4 2019. 81 funds tracked by Wall St. Rank hold GRTS as of Q2 2020.

  • Kore Private Wealth reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Kore Private Wealth sold 1,000 Gritstone bio, Inc. Common Stock shares in Q2 2020, an estimated $6K.
  • Kore Private Wealth first reported a position in Gritstone bio, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Kore Private Wealth's Gritstone bio, Inc. Common Stock position peaked at $9K in Q4 2019.
  • 81 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2020.

Based on Kore Private Wealth's 13F filing for Q2 2020, filed 14 Aug 2020.